Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Share News (SYNC)

Share Price Information for Syncona (SYNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 122.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.60 (0.493%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 122.00
SYNC Live PriceLast checked at -
Syncona is an Investment Trust

To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

Mon, 14th Sep 2020 17:21

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Henry Boot PLC - property investment and development company - Places struggling unit Starfish Commercial Ltd into voluntary liquidation. To book GBP200,000 in impairment costs as a result.

----------

Frontier IP Group PLC - London-based specialist in commercialising intellectual property - Portfolio firm Fieldwork Robotics awarded GBP84,000 grant from Innovate UK to boost robot technology in agriculture field.

----------

Tekcapital PLC - UK intellectual property investment company - Portfolio firm Guident acquires shock absorption technology designed for electric vehicles. Acquires exclusive license to a US patent from state of New York.

----------

Schroder Real Estate Investment Trust Ltd - UK-focused real estate investment trust - Completes 13 new lettings, renewals and reviews since June 30, adding GBP800,000 in rent. Rent collected for period ending September 30 now totals 82%. Notes 95% of rent collected from office portfolio, 92% in industrial and just 53% in retail and leisure.

----------

Residential Secure Income PLC - Investor in affordable shared ownership, retirement and local authority housing - Acquires six new build homes from Metropolitan Thames Valley Housing for GBP1.6 million in total.

----------

Supermarket Income REIT PLC - grocery property-focused real estate investment trust - Acquires Tesco PLC supermarket from CBRE Global Investors for GBP39.5 million.

----------

Duke Royalty Ltd - London-based royalty finance provider - Exits GBP2.0 million investment in Xtremepush Ltd, a Dublin-based business-to-business technology platform. Represents Duke first exit.

----------

Reabold Resources PLC - oil and gas project investor - Updates on IMIC-1 well, Romania. Liquids lifted from well and recovered substances include "sludge-like material". Gas flow observed after 12 hours was combination of methane and nitrogen. Well has now been shut in. Reabold holds interest in well operator ADX Energy Ltd via its 51% stake in Danube Petroleum Ltd.

----------

Power Metal Resources PLC - metals exploration and development company - Exercises option to earn-in to Silver Peak project, Canada. Has option to earn-in a 30% stake.

----------

Central Asia Metals PLC- metals explorer and developer - Reports short-term leakage of tailing from Sasa facility in North Macedonia. Says no one was harmed by leak but site is now not operational. Investigation into cause of the leak has kicked off.

----------

Oilex Ltd - Aberdeen-based oil and gas explorer - Amends sale and purchase agreement with Armour Energy Ltd over disposal of Cooper-Eromanga basin. Extends completion date to October 15 from September 15.

----------

ECR Minerals PLC - Australia-focused gold exploration and development company - Notes field mapping underway at targets at Bailieston project area in Victoria, Australia. Acquires diamond drill rig which can drill as deep as 1,300 metres. Identifies "high priority gold prospects".

----------

Salt Lake Potash Ltd - Australia-focused miner - Says Lake Way Project at Wiluna in Western Australia now 60% complete and on track for output in March quarter of 2021.

----------

IronRidge Resources Ltd - African focussed minerals exploration company - Enters into agreement with Australasian Gold Ltd for sale of non-core May Queen gold project asset in Australia. IronRidge to receive 4.5 million Australasian Gold shares, a 35% stake. IronRidge to invest AUD100,000 to provide Australasian Gold with working capital.

----------

Jangada Mines PLC - London-based minerals explorer - Preliminary economic assessment commissioned at Pitombeiras vanadium project, Brazil.

----------

Advance Energy PLC - upstream oil & gas company - Subsidiary Resolute Oil & Gas UK Ltd and 25%-owned investee Holywell Resources Ltd awarded, subject to documentation, a 50% interest in lock 43/25 and part-blocks 43/29, 43/30, 48/4 and 48/5 in the Oil & Gas Authority's 32nd offshore licensing round.

----------

Castillo Copper Ltd - Australia and Zambia focused base metal explorer - Finds new gold mineralisation at Big One deposit at Mt Oxide project, Australia. Will soon kick off drilling at Mt Oxide.

----------

Pensana Rare Earths PLC - operator of rare earths project in Angola - Reports "substantial" increase in mineral resource estimate at Longonjo project in Angola. Asset contains more than 2.3 times the previous estimate of measures and indicated resources.

----------

Mosman Oil & Gas Ltd - oil explorer - Completes drilling at Stanley-4 well in East Texas. Drilled completed to target depth of roughly 5,000 feet.

----------

Bluebird Merchant Ventures Ltd - Korean-focused gold development firm - Joint-venture partner Southern Gold does not accept an offer from Bluebird to acquire its 50% stake in Gubong and Kochang projects. Under terms of JV, an independent expert will determine a value which Bluebird must pay. Bluebird says it is "confident" it can acquire Southern Gold's interest "on attractive terms".

----------

SolGold PLC - Australian gold miner - Completes USD100 million royalty financing with Franco Nevada Corp in relation to Alpala copper and gold project, Ecuador. SolGold to use cash to progress project.

----------

Boku Inc - US-based mobile payments solution provider - Launches KakaoPay in Republic of Korea, allowing customers to make digital purchases on video game stores.

----------

MTI Wireless Edge Ltd - antenna manufacturer based in Israel - Secures new agreement worth USD500,000 for deployment of 5G backhaul solutions.

----------

Seeing Machines Ltd - computer vision technology company headquartered in London - To launch driver monitoring system for automotive industry. Kit is expected to be available to tier 1 automotive companies by end of 2020.

----------

Panoply Holdings PLC - IT service management company - Strong trading continued and has secured GBP10 million worth of new contract wins in first two months of second quarter. Expects annual earnings in line with expectations.

----------

Syncona Ltd - healthcare company with headquarters in London - Forms subsidiary named Resolution Therapeutics, a cell therapy company investigating liver disease treatment. Also co-led Series A financing for T-cell receptor firm Neogene Therapeutics. Makes USD19.0 million commitment.

----------

RTW Venture Fund Ltd - life sciences-focused investment firm - Leads USD50 million Series B financing in NiKang Therapeutics Inc. NiKang is ninth investment following RTW's October 2019 IPO.

----------

Vectura Group PLC - London-based drug delivery products - Partners with Monash University to develop an inhaled oxytocin aimed at preventing postpartum haemorrhage, vaginal bleeding, in childbirth. Vectura says to receive undisclosed revenue on a fee-for-service basis.

----------

Aeorema Communications PLC - London-based live events agency - To open New York events office, boosting global workforce to 24. Completes development of KIT virtual events platform.

----------

Brighton Pier Group PLC - Operator of Brighton Pier - Trading between July 4 and September 6 better than board expectations, with total revenue at 77% of year prior. Initially planned October for reopening of late night venues but virus uncertainty means it is yet to commit to a date.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 14:22

Syncona agrees to sell stake in investee company for GBP7.4 million

(Alliance News) - Syncona Ltd on Thursday said it has reached an agreement to sell one of its portfolio companies to US biotechnology firm, Century Therapeutics Inc.

Read more
4 Apr 2024 17:06

IN BRIEF: Syncona notes investee Achilles's annual loss narrows

Syncona Ltd - London-based investor in healthcare companies - Notes that the loss of investee and clinical-stage biopharmaceutical company Achilles Therapeutics PLC narrows by 2.7% to USD68.2 million in 2023 from USD71.1 million in 2022. General and administrative costs contract by 19% to USD17.0 million from USD21.1 million. According to Syncona's website, the company has a 25% stake in Achilles.

Read more
14 Mar 2024 14:16

Syncona portfolio company Autolus posts widened loss for 2023

(Alliance News) - Syncona Ltd on Thursday noted the 2023 results of one of its life science portfolio companies, which showed a widened loss and an increase in annual expenses.

Read more
12 Feb 2024 18:01

IN BRIEF: Freeline shareholders approve Syncona acquisition

Syncona Ltd - London-based investor in healthcare companies - Freeline Therapeutics Holdings PLC shareholders approve acquisition by Syncona.

Read more
8 Feb 2024 13:45

UPDATE: Syncona portfolio strengthens thanks to Autolus

(Alliance News) - Syncona Ltd on Thursday said its portfolio company Autolus Therapeutics PLC has struck a deal to work with BioNTech to commercialise its CAR-T programmes.

Read more
8 Feb 2024 09:41

Syncona portfolio strengthens in third quarter thanks to Autolus

(Alliance News) - Syncona Ltd on Thursday reported a recent increase to the value of its portfolio, as the company said it was in a strong position to push forward its main life science companies.

Read more
8 Feb 2024 09:04

Syncona NAV grows in Q3

(Sharecast News) - Life sciences investor Syncona said on Thursday that its net asset value had grown in the three months ended 31 December, driven by a prioritisation of capital allocation across its portfolio to enable the delivery of key inflection points.

Read more
22 Jan 2024 12:19

IN BRIEF: Syncona notes FDA acceptance of Autolus's BLA for obe-cel

Syncona Ltd - London-based investor in healthcare companies - The US Food & Drug Administration accepts Autolus Therapeutics PLC's biologics licence application for obe-cel for patients with relapsed/refractory adult B-cell acute lymphoblastic leukaemia. The FDA has set a target action date of November 16 for reviewing the application, Syncona says. Further, Autolus is on track to submit a marketing authorisation application to the EU's European Medicines Agency in the first half of 2024.

Read more
19 Jan 2024 08:36

Syncona says Freeline trial for Gaucher disease treatment positive

(Alliance News) - Syncona Ltd on Friday noted Freeline Therapeutics Holdings PLC's positive data for Gaucher disease treatment.

Read more
4 Dec 2023 09:37

IN BRIEF: Syncona notes Beacon's "encouraging" AGTC-501 trial data

Syncona Ltd - London-based investor in healthcare companies - Says portfolio company, Beacon Therapeutics has presented three-month data from the phase 2 Skyline trial of its viral vector-based gene therapy AGTC-501 in X-linked retinitis pigmentosa at the Floretina ICOOR 2023 Congress in Rome. Notes AGTC-501 shows an "encouraging efficacy profile", showing a "significant improvement" in retinal sensitivity. Adds that there are no clinically significant safety events related to AGTC-501.

Read more
27 Nov 2023 19:03

TRADING UPDATES: Molten Ventures completes raise; Saietta proposes one

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
22 Nov 2023 14:30

IN BRIEF: Syncona agrees to buyout deal with Freeline Therapeutics

Syncona Ltd - London-based investor in healthcare companies - Agrees to acquire all remaining stock in investee Freeline Therapeutics Holdings PLC for USD6.50 in cash per share, valuing Freeline at approximately USD28.3 million. Syncona currently owns 49.7% of shares in Freeline. The company will provide up to USD15 million of financing in conjunction with the acquisition to enable Freeline to meet its near-term cash requirements and continue advancing its lead programme FLT201, a potential gene therapy for Gaucher disease.

Read more
16 Nov 2023 10:34

Syncona reports declining asset value as investment head steps down

(Alliance News) - Syncona Ltd on Thursday said net asset value decreased as it swung to a negative return in its latest half year, but that it is well-positioned for future growth thanks to its "rich pipeline".

Read more
16 Nov 2023 08:44

Syncona net asset value falls, co-founder steps down

(Sharecast News) - Life science specialist Syncona reported a net asset value of £1.2bn at the end of its first half on Thursday, down from £1.25bn on 31 March, with a net asset value return of -4.2% during the period.

Read more
14 Nov 2023 11:29

IN BRIEF: Syncona notes investee company's quarterly loss

Syncona Ltd - London-based investor in healthcare companies - Says portfolio company Achilles Therapeutics reports that pretax loss widened to USD16.7 million in the third quarter of 2023 from USD12.4 million the year before, as operating expenses rose 19% to USD19.1 million from USD16.0 million a year ago. Achilles is a Philadelphia, US-based clinical-stage biopharmaceutical company which develops novel cancer immunotherapies. Syncona owns a 25% stake in Achilles.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.